These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1903407)

  • 21. [Efficacy and tolerability of enprostil in the treatment of duodenal ulcer. Comparison with cimetidine].
    Frexinos J; Andrieu J; Evreux M; Guerre J; Michel H; Vicari F; Joubert M
    Gastroenterol Clin Biol; 1989; 13(2):188-92. PubMed ID: 2496000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enprostil and ranitidine: comparative efficacy and safety in patients with duodenal ulcer.
    Mackinnon M; Alp M; Austad WI; Byrnes D; Cowen A; Duggan J; Pirola R; Thomas M; Ward M
    Aust N Z J Med; 1987 Jun; 17(3):316-20. PubMed ID: 3118861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine 300 mg at bedtime is effective for gastric ulcers: a 12-wk, multicenter, randomized, double-blind, placebo-controlled comparison. The Ranitidine 300 mg HS Gastric Ulcer Study Group.
    Johnson JA; Euler AR; Northcutt AR; McSorley DJ
    Am J Gastroenterol; 1993 Jul; 88(7):1071-5. PubMed ID: 8317408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
    Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of stomach ulcer--a comparison between the low dosage antacid hydrotalcite and ranitidine--results of a randomized multicenter double-blind study. Talcivent Study Group].
    Holtermüller KH; Liszkay M; Bernard I; Haase W
    Z Gastroenterol; 1992 Oct; 30(10):717-21. PubMed ID: 1441674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinical trial on the effect of aluminum containing antacids on the course of duodenal ulcer healing and morphology of the gastric mucosa].
    Mach T
    Folia Med Cracov; 1995; 36(1-4):3-20. PubMed ID: 8834664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
    Kager L; Lindberg G; Nilsson LH; Seensalu R; Backman L; Granström L; Kollberg B; Sidenvall L; Moberg S; Sörstad J
    Hepatogastroenterology; 1991 Aug; 38(4):287-90. PubMed ID: 1937372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
    Simon B; Reinicke HG; Dammann HG; Müller P
    Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of gastric ulcer with enprostil.
    Navert H
    Am J Med; 1986 Aug; 81(2A):75-9. PubMed ID: 3092660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of gastric ulcer with ranitidine.
    Schulz TB; Berstad A; Rydning A; Frislid K
    Scand J Gastroenterol; 1984 Jan; 19(1):119-21. PubMed ID: 6324332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative.
    Konturek JW; Hengst K; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1997 Oct; 32(10):980-4. PubMed ID: 9361169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment.
    Hui WM; Lam SK; Lau WY; Branicki FJ; Lok AS; Ng MM; Lai CL; Poon GP
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():35-43. PubMed ID: 2491360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magaldrate compared to ranitidine. The healing rate of stomach ulcer using magaldrate (100 mmol/d) versus ranitidine (300 mg/d)].
    Miederer SE; Mayershofer R; Löffler A
    Fortschr Med; 1986 Dec; 104(3):921-5. PubMed ID: 2881865
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
    Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer.
    Simon B; Bergemann W; Bouzo H; Hüttemann W; Hotz F; Müller P; Rösch W
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():41-5. PubMed ID: 1823066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.